NCT04398238View on ClinicalTrials.gov

Transfusion Rates in Total Hip Replacement Before/After the Implementation of a Patient Blood Management Program.

CompletedOBSERVATIONAL

Enrollment

400

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

November 25, 2022

Study Completion Date

April 4, 2023

Conditions

Anemia (Diagnosis)Iron-deficiencyTransfusionArthroplasty

Interventions

COMBINATION_PRODUCT

evaluation by transfusion medicine specialist

screening for anemia causes and treatment: iron/folate/vitamin B12 supplementation, Erythropoietin administration if indicated

Trial Locations (1)

40128

Sandra Giannone, Bologna

All Listed Sponsors

lead

Istituto Ortopedico Rizzoli

OTHER

NCT04398238 - Transfusion Rates in Total Hip Replacement Before/After the Implementation of a Patient Blood Management Program. | Biotech Hunter | Biotech Hunter